• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性和女性杂合 FDNQ175 小鼠亨廷顿病表型进展的比较。

Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.

机构信息

University of Ottawa Brain and Mind Research Institute, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.

Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.

出版信息

Mol Brain. 2023 Sep 19;16(1):67. doi: 10.1186/s13041-023-01054-6.

DOI:10.1186/s13041-023-01054-6
PMID:37726802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10508000/
Abstract

Huntington's Disease (HD) is an inherited autosomal dominant neurodegenerative disorder that leads to progressive motor and cognitive impairment due to the expansion of a polyglutamine (CAG) repeat in the N-terminal region of the huntingtin (Htt) protein. The creation of HD mouse models represents a critical step in the research for HD treatment. Among the currently available HD mouse models, the zQ175 knock-in mouse line is the first to display robust disease phenotype on a heterozygous background. The newer FDNQ175 mouse model is derived from the zQ175 mouse line and presents a more aggressive phenotype. Moreover, increasing evidence has implicated sex as a contributing factor in the progression of HD symptoms. Here, we compared the progression of HD phenotypes in male and female heterozygous FDNQ175 mice. We found that both male and female heterozygous mice showed deficits in forelimb grip strength and cognition as early as 6 months of age. However, female FDNQ175 mice were less vulnerable to HD-associated decline in limb coordination and movement. Neither male nor female FDNQ175 mice exhibited reduced locomotor activity in the open field or exhibit consistent differences in anxiety at 6-12 months of age. Both male and female FDNQ175 mice exhibited increased numbers of huntingtin aggregates with age and 8-month-old female FDNQ175 mice had significantly more aggregates than their male counterparts. Taken together, our results provide further evidence that sex can influence the progression of HD phenotype in preclinical animal models and must be taken into consideration for future HD research.

摘要

亨廷顿病(HD)是一种遗传性常染色体显性神经退行性疾病,由于亨廷顿(Htt)蛋白 N 端区域内的多聚谷氨酰胺(CAG)重复扩展,导致进行性运动和认知障碍。创建 HD 小鼠模型是 HD 治疗研究的关键步骤。在目前可用的 HD 小鼠模型中,zQ175 敲入鼠系是第一个在杂合背景下显示出稳健疾病表型的模型。更新的 FDNQ175 小鼠模型源自 zQ175 鼠系,表现出更具侵袭性的表型。此外,越来越多的证据表明,性别是影响 HD 症状进展的一个因素。在这里,我们比较了雄性和雌性杂合 FDNQ175 小鼠中 HD 表型的进展。我们发现,雄性和雌性杂合小鼠在 6 个月大时就表现出前肢握力和认知缺陷。然而,雌性 FDNQ175 小鼠对与 HD 相关的肢体协调和运动能力下降的敏感性较低。雄性或雌性 FDNQ175 小鼠在 6-12 个月大时均未表现出运动活性降低或焦虑程度的一致差异。雄性和雌性 FDNQ175 小鼠随年龄增长均表现出亨廷顿蛋白聚集体数量增加,8 月龄雌性 FDNQ175 小鼠的聚集体数量明显多于雄性。总之,我们的结果进一步证明,性别可以影响临床前动物模型中 HD 表型的进展,在未来的 HD 研究中必须考虑到这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/4618622b134c/13041_2023_1054_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/3bae8ad05825/13041_2023_1054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/0341b89b391b/13041_2023_1054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/c3a7e5441afa/13041_2023_1054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/c75399d8c6d2/13041_2023_1054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/e74cd4e44ff6/13041_2023_1054_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/de72e667bf28/13041_2023_1054_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/4618622b134c/13041_2023_1054_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/3bae8ad05825/13041_2023_1054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/0341b89b391b/13041_2023_1054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/c3a7e5441afa/13041_2023_1054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/c75399d8c6d2/13041_2023_1054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/e74cd4e44ff6/13041_2023_1054_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/de72e667bf28/13041_2023_1054_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/10508000/4618622b134c/13041_2023_1054_Fig7_HTML.jpg

相似文献

1
Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.男性和女性杂合 FDNQ175 小鼠亨廷顿病表型进展的比较。
Mol Brain. 2023 Sep 19;16(1):67. doi: 10.1186/s13041-023-01054-6.
2
Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.全面行为和分子表征一个新的亨廷顿病的敲入小鼠模型:zQ175。
PLoS One. 2012;7(12):e49838. doi: 10.1371/journal.pone.0049838. Epub 2012 Dec 20.
3
Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.代谢型谷氨酸受体 2/3 的激活可改善杂合 zQ175 亨廷顿病小鼠的运动表现并减少其病理改变。
J Pharmacol Exp Ther. 2021 Oct;379(1):74-84. doi: 10.1124/jpet.121.000735. Epub 2021 Jul 30.
4
VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.VGLUT3 缺失可挽救亨廷顿病 zQ175 小鼠模型的运动缺陷和神经元丢失。
J Neurosci. 2023 Jun 7;43(23):4365-4377. doi: 10.1523/JNEUROSCI.0014-23.2023. Epub 2023 Apr 13.
5
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.具有225个CAG重复序列的新型亨廷顿舞蹈病BAC小鼠模型表现出早期广泛且稳定的退化表型。
J Huntingtons Dis. 2015;4(1):17-36.
6
Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.定量脑电图分析为亨廷顿舞蹈病zQ175基因敲入小鼠模型的疾病发作和进展提供了早期指标。
Sleep. 2016 Feb 1;39(2):379-91. doi: 10.5665/sleep.5448.
7
Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.代谢型谷氨酸受体5拮抗剂可减轻雄性和雌性杂合子zQ175亨廷顿病小鼠的病理变化并不同程度改善症状。
Front Mol Neurosci. 2022 Feb 2;15:801757. doi: 10.3389/fnmol.2022.801757. eCollection 2022.
8
Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.亨廷顿病 ZQ175 基因敲入小鼠模型的神经生理和行为变化特征、MRI 脑容量测定和 1H MRS。
PLoS One. 2012;7(12):e50717. doi: 10.1371/journal.pone.0050717. Epub 2012 Dec 20.
9
Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.转基因和基因敲入HTT小鼠的认知缺陷与亨廷顿舞蹈症患者的认知缺陷相似。
J Huntingtons Dis. 2014;3(2):145-58. doi: 10.3233/JHD-130061.
10
A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.亨廷顿舞蹈病HdhQ111小鼠模型的纵向运动特征分析
J Huntingtons Dis. 2016 May 31;5(2):149-61. doi: 10.3233/JHD-160191.

引用本文的文献

1
A bacterial artificial chromosome mouse model of amyotrophic lateral sclerosis manifests 'space cadet syndrome' on two FVB backgrounds.肌萎缩侧索硬化症的细菌人工染色体小鼠模型在两种FVB背景下表现出“太空学员综合征”。
Dis Model Mech. 2025 Feb 1;18(2). doi: 10.1242/dmm.052221. Epub 2025 Feb 13.
2
Deep behavioural phenotyping of the Q175 Huntington disease mouse model: effects of age, sex, and weight.Q175 亨廷顿病小鼠模型的深入行为表型分析:年龄、性别和体重的影响。
BMC Biol. 2024 May 23;22(1):121. doi: 10.1186/s12915-024-01919-9.

本文引用的文献

1
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotype.mGluR5 缺失导致与年龄相关的突触可塑性损伤,并且不能改善亨廷顿病表型。
Sci Rep. 2022 May 28;12(1):8982. doi: 10.1038/s41598-022-13029-z.
2
Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.代谢型谷氨酸受体5拮抗剂可减轻雄性和雌性杂合子zQ175亨廷顿病小鼠的病理变化并不同程度改善症状。
Front Mol Neurosci. 2022 Feb 2;15:801757. doi: 10.3389/fnmol.2022.801757. eCollection 2022.
3
A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.
一种毒蕈碱型乙酰胆碱受体(M1 mAChR)的正变构调节剂可改善 APPswe/PSEN1ΔE9 雌性小鼠的病理和认知缺陷。
Br J Pharmacol. 2022 Apr;179(8):1769-1783. doi: 10.1111/bph.15750. Epub 2022 Feb 3.
4
Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.代谢型谷氨酸受体 2/3 的激活可改善杂合 zQ175 亨廷顿病小鼠的运动表现并减少其病理改变。
J Pharmacol Exp Ther. 2021 Oct;379(1):74-84. doi: 10.1124/jpet.121.000735. Epub 2021 Jul 30.
5
Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database.亨廷顿舞蹈症的性别差异:评估“亨廷顿舞蹈症注册研究(Enroll-HD)”数据库
Mov Disord Clin Pract. 2021 Mar 8;8(3):420-426. doi: 10.1002/mdc3.13178. eCollection 2021 Apr.
6
Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.Aβ 寡聚体以性别选择性方式诱导阿尔茨海默病模型小鼠的病理生理学 mGluR5 信号。
Sci Signal. 2020 Dec 15;13(662):eabd2494. doi: 10.1126/scisignal.abd2494.
7
mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent.代谢型谷氨酸受体5(mGluR5)对阿尔茨海默病小鼠神经病理学的影响具有疾病阶段依赖性。
ACS Pharmacol Transl Sci. 2020 Mar 12;3(2):334-344. doi: 10.1021/acsptsci.0c00013. eCollection 2020 Apr 10.
8
Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease.年龄和性别相关变化在皮质和纹状体一氧化氮合酶在亨廷顿病 Q175 小鼠模型中。
Nitric Oxide. 2019 Feb 1;83:40-50. doi: 10.1016/j.niox.2018.12.002. Epub 2018 Dec 5.
9
Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease.亨廷顿病小鼠模型中亨廷顿抑制可恢复认知功能。
Sci Transl Med. 2018 Oct 3;10(461). doi: 10.1126/scitranslmed.aar3959.
10
Sex Differences in Medium Spiny Neuron Excitability and Glutamatergic Synaptic Input: Heterogeneity Across Striatal Regions and Evidence for Estradiol-Dependent Sexual Differentiation.中等棘状神经元兴奋性和谷氨酸能突触输入的性别差异:纹状体区域的异质性及雌二醇依赖性性别分化的证据
Front Endocrinol (Lausanne). 2018 Apr 18;9:173. doi: 10.3389/fendo.2018.00173. eCollection 2018.